Track topics on Twitter Track topics that are important to you
First Wave Technology is a medical device company developing products for the acute care and long- term care markets. Our focus is to significantly enhance healthcare innovation by focusing on products which, historically, have not seen meaningful change. Our suite of medical devices are centered around improving the ease and accuracy of pharmaceutical delivery and providing a better healthcare experience for both patients and caregivers.
First Wave identifies innovative medical device opportunities, usually originating out of universities otherwise overlooked by other investors. We believe that high-return opportunities exist in many non-traditional markets that go unnoticed by the majority of venture capitalists who typically target higher-profile centers of excellence for emerging innovation. At First Wave, emphasis is placed on addressing meaningful patient care issues significantly impacting today’s healthcare landscape.
First Wave looks to invest in products that:
First Wave works by offering:
(1) First Crush® automated pill crusher is an automated technology that allows patients to receive their medication in a manner that is more accurately dosed, has a higher grade of refinement, and is easier to swallow. These attributes support better patient compliance with prescribed medication and ultimately a healthier patient.
(2) Clarity-IA® is a next-generation anesthesia system expanding the use of inhaled anesthetics worldwide. Currently undergoing 501(k) approval, the Clarity-IA system is based on a licensed portfolio of 55 patents and applications from the State University of New York at Buffalo. The system and platform technology have characteristics that include: (1) the ability to cost-effectively convert existing ventilators into an anesthesia machine, (2) a self-regulation technology ensuring accurate dosing for patients, and (3) a disposable device design that reduces the risk of environmental and patient contamination by isolating airflow between the ventilator and patient.
First Wave’s management, board of advisors, and scientific teams have experience in: medical device development, venture capital, clinical research, manufacturing, business development, and sales and marketing.
99 MedTech Drive
Batavia, New York 14020
GE Healthcare, a unit of General Electric Company, today announced it has acquired Wave Biotech LLC, a supplier of innovative disposable manufacturing technologies for the biopharmaceutical industry
Does this flu season have a second wave? Flu activity continues to decrease, but more influenza B viruses have been reported, which are worse for children.
To identify novel therapies to be developed by Wave for the treatment of genetic neuromuscular disorders.
August 15, 2018 – Batavia, New York – First Wave Products Group, LLC, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), anno...
Pfizer has selected the final two targets in a two-year-old, up-to-$911 million collaboration with Wave Life Sciences to develop new treatments for metabolic hepatic diseases, including nonalcoholic s...
Wave Life Sciences' WVE-210201, being developed as a treatment for patients with Duchenne muscular dystrophy, received orphan -More-
The heat wave of 2018 is sweeping across the Northern Hemisphere, and it has already claimed lives. Here's how to reduce the risk of heat-related illness in extreme temperatures.
Cardiovascular device firm V-Wave Ltd. raised $2mm in its first financing round to BRM Group and Pontifax. The company is developing a minimally invasive implanted interatrial shunt for patients with ...
BIO-CORNEUM HC Advanced Scar Supervision Anti-Itch Gel
Omeprazole Delayed Release Tablets, 20 mg
The a-wave in left atrial pressure (LAP) is often not observed after cardioversion (CV). We hypothesized that repeated atrial fibrillation (AF) occurs in patients who do not show a-wave pattern after ...
By improving the existing surgical technologies for dacryocystitis, one enhances the effectiveness of patient rehabilitation.
The Partial Wave Method is unique in that it establishes a foundation on which various elastodynamic guided waves can be compared. In this paper, the method is used to compare quasi-Rayleigh waves and...
Extracorporeal shock wave therapy (ESWT), including radial shock wave (RaSW) and focused shock wave (FoSW) types, is widely used for managing tendinopathies. The difference in efficacy between the 2 s...
A reduction in surface electrocardiogram (ECG) P wave duration and dispersion is associated with improved outcomes in atrial fibrillation ablation. We investigated the effects of different ablation st...
The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then...
T-wave alternans is a test that looks at microvolt changes in the T-wave on a beat to beat basis. The presence or absence of such changes has been shown to predict or exclude future arrhy...
T-wave alternans is an electrocardiographic finding that has been shown to predict the occurrence of future cardiac arrhythmias in patients who have had a heart attack. What is unknown ab...
Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters a...
Extracorporeal Shock Wave treatment is a well established treatment in orthopedics. Considerable success has been reported after treatment of various soft tissue pathologies (Tendinitis, h...
V-Wave is a privately held company with offices in Israel and the U.S. The major investors are Israeli venture firms BRM Group and Pontifax. For further information on V-Wave, vis...
Increasingly, new medicines are offering hope to those suffering from chronic disease. But for many drugs, achieving optimal outcomes depends on tailoring therapies to each individual patient. Wave 80...
Electrocardiograph ECG-101 Digital Single channel ECG-101G Digital Single Channel & Wave LCD ECG-300 Digital Three Channel & Analyzes ECG-803 Digital Three Channel & Wave LCD Without AnalyzesECG-1...
First Wave Bio Inc. is a privately held biopharmaceutical company based in Ann Arbor, MI. The company was founded by an experienced group of scientists, physicians, executives, an...
Third Wave is a growing leader in molecular diagnostics, providing DNA and RNA analysis products to clinical, research, and agricultural customers. Our company is one of the only companies in the mole...
We have published hundreds of First Wave Technologies, Inc. news stories on BioPortfolio along with dozens of First Wave Technologies, Inc. Clinical Trials and PubMed Articles about First Wave Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of First Wave Technologies, Inc. Companies in our database. You can also find out about relevant First Wave Technologies, Inc. Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...